Copy and paste this code to insert a reference to this article in your
blog or online community profile:
 
 
Will Display Like this:
 
Unveiling the Potential of Repurposing FDA-Approved Drugs in Pancreatic Cancer
J Mol Biomark Diagn 2018, 9:1. 9:1, (2018)
https://doi.org/10.4172/2155-9929.1000e128